Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquila En Regulatory News (AEET)

Share Price Information for Aquila En (AEET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.75
Bid: 53.50
Ask: 56.00
Change: 0.00 (0.00%)
Spread: 2.50 (4.673%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 54.75
AEET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Day of Dealings

2 Jun 2021 08:00

RNS Number : 4996A
Aquila Energy Efficiency Trust PLC
02 June 2021
 

2 June 2021

 

LEI: 213800AJ3TY3OJCQQC53

 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SINGAPORE, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY MARKETED), OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION IS UNLAWFUL, OR TO ANY NATIONAL, RESIDENT OR CITIZEN OF THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SINGAPORE, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN TO PROFESSIONAL INVESTORS IN CERTAIN EEA MEMBER STATES FOR WHICH MARKETING APPROVAL HAS BEEN OBTAINED)

 

Aquila Energy Efficiency Trust PLC

(the "Company")

 

First day of dealings

 

Aquila Energy Efficiency Trust PLC is pleased to announce the commencement of dealings in its Ordinary Shares at 8:00 a.m. today on the premium segment of the main market of the London Stock Exchange and admission to the premium segment of the Official List of the Financial Conduct Authority ("Admission").

 

The Company's issued ordinary share capital immediately following Admission will comprise 100,000,000 Ordinary Shares and this is the total number of Ordinary Shares with voting rights in the Company. This figure (100,000,000) should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Dealing codes

 

The dealing codes for the Ordinary Shares will be as follows:

 

Sterling Quote

Euro Quote

ISIN

GB00BN6JYS78

GB00BN6JYS78

SEDOL

BN6JYS7

BL6K7R6

Ticker

AEET

AEEE

 

Director participation

 

Immediately following Admission, the beneficial interests of the Directors in the issued share capital of the Company will be as follows:

 

Director

Number of ordinary shares

% of issued share capital

Miriam Greenwood

24,000

0.024%

Lisa Arnold

20,100

0.020%

Laura Sandys

15,000

0.015%

Nicholas Bliss

20,000

0.020%

 

For further information please contact:

 

Aquila Capital

 

Via Buchanan

Peel Hunt (Sole Sponsor, Placing Agent and Intermediaries Offer Adviser) Luke Simpson, Huw Jeremy, Tom Pocock (Investment Banking)

Alex Howe, Chris Bunstead, Ed Welsby, Richard Harris (Sales)

Alistair Boyle (Intermediaries)

Sohail Akbar (ECM)

 

020 7418 8900

Buchanan (Financial PR)

Charles Ryland, Henry Wilson

 

020 7466 5000

 

All capitalised terms used and not defined herein shall have the same meaning as in the Prospectus.

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUARKRARUNRAR
12
Date   Source Headline
6th Mar 20242:45 pmRNSUnaudited NAV and Return of Capital
19th Jan 20242:00 pmRNSUpdate re: Investment Adviser
16th Nov 202310:54 amRNSDirector Declaration
27th Sep 20237:00 amRNSHalf-year Report
25th Sep 20234:00 pmRNSHolding(s) in Company
16th Aug 20237:00 amRNSShareholder Update
11th Aug 20237:00 amRNSNet Asset Value as at 30 June 2023
14th Jun 20235:21 pmRNSResult of AGM
2nd May 20237:01 amRNSNotice of AGM
2nd May 20237:00 amRNSFinal Results
13th Apr 20231:28 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSAppointment of Sole Corporate Broker
28th Feb 20233:36 pmRNSResult of General Meeting
27th Feb 20231:24 pmRNSGeneral Meeting Update on Proxy Votes
20th Feb 20237:00 amRNSPurchase of shares in relation to inv.advisory fee
16th Feb 20237:01 amRNSDividend Declaration
16th Feb 20237:00 amRNSNAV and Fact Sheet as at 31 December 2022
13th Feb 20237:00 amRNSPublication of Circular
30th Jan 20237:00 amRNSPositive Investment Update
17th Jan 20237:00 amRNSChange of Name of Company Secretary
20th Dec 20225:32 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSTrading Update
13th Dec 20224:03 pmRNSDirector/PDMR Shareholding
3rd Nov 20225:31 pmRNSChange of AIFM's Name
3rd Nov 20227:00 amRNSDividend Declaration
2nd Nov 202211:58 amRNSAppointment of Non-executive Director
15th Sep 20224:22 pmRNSPurchase of shares re investment advisory fees
15th Sep 20227:00 amRNSDividend Declaration
15th Sep 20227:00 amRNSHalf-year Report
12th Aug 20225:55 pmRNSHolding(s) in Company
12th Aug 20227:00 amRNSFactsheet as at 30 June 2022
12th Aug 20227:00 amRNSNet Asset Value(s)
25th Jul 20222:06 pmRNSResult of General Meeting
25th Jul 20227:00 amRNSTrading Update
29th Jun 20225:03 pmRNSDirector/PDMR Shareholding
28th Jun 20224:30 pmRNSResult of AGM
28th Jun 20224:06 pmRNSPurchase of shares re investment advisory fees
24th Jun 20227:00 amRNSAnnual Financial Report
1st Jun 20227:00 amRNSNotice of AGM
29th Apr 20227:00 amRNSAppointment of Non-executive Director
21st Apr 20227:00 amRNSResult of Investment Strategy Review
23rd Feb 20223:15 pmRNSHolding(s) in Company
17th Feb 20227:00 amRNSFactsheet as at 31 December 2021
31st Jan 20227:00 amRNSCompany Update
6th Dec 20214:55 pmRNSChange of Registered Office
21st Oct 20217:00 amRNSReduction of the share premium account
17th Sep 20216:16 pmRNSHolding(s) in Company
28th Jun 20213:23 pmRNSHolding(s) in Company
28th Jun 20213:18 pmRNSHolding(s) in Company
28th Jun 20212:55 pmRNSTotal Voting Rights
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.